≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_COLON_EXALLC for full statistics.

Carcinoma in situ of colon

DOID EFO Endpoint Browser

CD2_INSITU_COLON

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_COLON
514270

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D01.0&
  • Hospital discharge: ICD-9 — 2303
  • Cause of death: ICD-10 — D01.0&
  • Cause of death: ICD-9 — 2303
  • Cancer registry: Topography ICD-O-3 — C18
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 2

3 out of 7 registries used, show all original rules.

438

4. Check minimum number of events

None

438

5. Include endpoints

None

438

6. Filter based on genotype QC (FinnGen only)

438

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D01
Name in latin
Carcinoma in situ ani

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 438 175 263
Unadjusted period prevalence (%) 0.09 0.06 0.12
Median age at first event (years) 71.38 71.88 71.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
393
Matched controls
3928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJF32
NOMESCO Finland
Coloscopy
8.8
84.8
262
728
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
22.6
58.3
86
48
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
15.2
57.2
99
85
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
12.0
53.5
104
114
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
11.1
52.6
107
128
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
37.5
51.9
66
21
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
15.4
48.2
82
66
8263/2-C18.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of cecum
+∞
43.5
41
*
C187, 8211, 2
ICD-O-3
NA
+∞
42.5
40
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
17.2
36.7
59
40
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
6.5
35.3
101
198
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
20.2
35.2
53
30
8263/2-C18.7
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of sigmoid colon
+∞
31.7
30
*
C189, 8211, 2
ICD-O-3
NA
+∞
31.7
30
*
K63.5
ICD-10 Finland
Polyp of colon
30.3
30.9
41
15
WX402
NOMESCO Finland
General anaesthesia
4.5
30.6
128
381
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
12.3
28.8
53
49
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.1
25.6
66
109
8263/2-C18.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS
+∞
25.3
24
*
C180, 8211, 2
ICD-O-3
NA
+∞
25.3
24
*
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
13.3
24.4
43
36
B01AB05
ATC
enoxaparin; parenteral
3.0
22.1
179
860
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.8
21.9
65
129
C187, 8148, 2
ICD-O-3
NA
+∞
21.0
20
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
6.8
20.7
54
90
C189, 8148, 2
ICD-O-3
NA
+∞
18.9
18
*
UJF32
SPAT
NA
12.3
18.9
34
30
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
3.2
18.6
118
466
8211/2-C18.2
ICD-O-3
Tubular adenocarcinoma in situ of ascending colon
+∞
16.8
16
*
C180, 8148, 2
ICD-O-3
NA
+∞
16.8
16
*
JFA15
SPAT
NA
35.0
15.9
20
6
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
166.3
15.6
16
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
7.3
15.4
37
55
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
15.0
71
223
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
14.8
80
277
8263/2-C18.2
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of ascending colon
+∞
14.7
14
*
B01AB10
ATC
tinzaparin; parenteral
4.2
14.0
56
151
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
15.8
13.2
21
14
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
7.3
12.7
30
44
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
48.2
11.9
14
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
9.4
11.9
24
27
8140/2-C18.7
ICD-O-3
Adenocarcinoma in situ, NOS, of sigmoid colon
+∞
11.5
11
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
11.2
145
820
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.3
10.9
33
67
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
9.6
10.6
21
23
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
10.5
10.6
20
20
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.5
10.2
48
149
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
20.7
9.9
14
7
JN4AD
NOMESCO Finland
Body CT examination
3.0
9.7
56
203
C184, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
C186, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
C184, 8148, 2
ICD-O-3
NA
+∞
9.4
9
*
C188, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
16.1
9.1
14
9
130
Kela drug reimbursment
Malignant tumour
2.9
8.6
54
206
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
20.6
8.5
12
6
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
91.9
8.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
13.1
8.4
14
11
C182, 8148, 2
ICD-O-3
NA
+∞
8.4
8
*
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
+∞
8.4
8
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
8.3
62
264
L01BC06
ATC
capecitabine; oral
4.0
8.2
32
86
JN4BD
NOMESCO Finland
Extensive body CT
2.5
8.1
68
305
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.7
8.1
34
97
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.7
8.0
34
98
WX600
NOMESCO Finland
Single shot through catheter
8.0
8.0
17
22
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
18.8
7.6
11
6
C03CA01
ATC
furosemide; systemic
1.9
7.4
137
868
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
11.2
7.3
13
12
JFB30
NOMESCO Finland
Right hemicolectomy
6.9
6.9
16
24
R4110
NOMESCO Finland
Physiotherapy
1.9
6.7
123
768
8263/2-C18.4
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of transverse colon
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.2
342
3007
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
12.8
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
292
449
17.51
212.10
1.9
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
235
478
9.45
126.01
5.4
4.5
ug/l
14.5
36.3
0.64
199
408
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
325
1784
4.19
40.29
5.3
4.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
319
1747
4.04
39.25
7.0
4.9
g/l
34.0
35.0
2.36
307
1635
(40768804) Tissue Pathology biopsy report
277
1444
3.50
35.43
2.6
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
219
1006
3.35
34.20
2.9
2.2
mg/l
3.8
3.2
1.24
189
864
(3004789) Transferrin [Mass/volume] in Serum or Plasma
160
611
3.55
33.62
2.7
2.5
g/l
2.4
2.3
2.07
152
566
(3044640) Blood type and Crossmatch panel - Blood
249
1256
3.28
32.85
3.5
2.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
155
590
3.52
32.59
2.7
2.5
%
16.3
22.1
6.37
137
500
(3022948) Iron [Moles/volume] in Serum or Plasma
163
659
3.35
30.86
2.8
2.5
umol/l
10.2
12.5
3.65
157
608
(3001122) Ferritin [Mass/volume] in Serum or Plasma
265
1457
3.07
28.83
3.6
2.7
ug/l
113.4
154.0
2.19
244
1324
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
193
944
2.87
25.16
3.1
2.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
112
404
3.38
24.91
2.6
2.3
g/l
0.2
0.2
0.60
102
377
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
81
237
3.97
24.67
12.1
8.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
322
2119
2.96
22.74
10.1
6.7
umol/l
13.9
11.9
0.67
309
2011
(40768797) Stomach Pathology biopsy report
124
537
2.83
19.59
1.3
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
278
1799
2.49
18.54
11.8
10.1
inr
1.4
1.3
0.38
87
498
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
63
192
3.66
17.87
4.2
3.7
u/ml
76.1
7309.5
0.75
56
160
(3003396) Base excess in Arterial blood by calculation
120
535
2.71
17.73
10.5
6.9
mmol/l
0.3
1.2
1.29
102
434
(3023368) Bacteria identified in Blood by Culture
208
1201
2.39
17.66
6.0
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
331
2355
2.66
17.51
8.1
4.9
mmol/l
7.1
6.8
1.70
324
2219
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
386
2983
3.48
17.32
12.6
8.1
u/l
89.2
79.9
1.67
379
2792
(3027945) Reticulocytes/100 erythrocytes in Blood
115
509
2.71
17.18
2.6
2.5
%
1.9
1.8
0.50
107
461
(3048689) Calprotectin [Mass/mass] in Stool
93
377
2.86
16.37
2.1
2.2
ug/g
222.8
142.3
1.04
77
303
(3000991) Gas panel - Venous blood
89
354
2.90
16.22
13.2
7.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
92
387
2.74
15.02
3.0
2.6
e9/l
73.2
70.3
0.26
68
308
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
286
1988
2.26
14.58
10.7
6.9
mmol/l
1.2
1.2
3.86
246
1678
(4035726)
85
350
2.77
14.42
1.3
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
208
1280
2.19
14.33
3.4
3.4
e6/l
56.9
105.0
0.44
149
1000
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
451
2.58
14.14
4.0
3.0
umol/l
10.4
9.3
0.12
87
402
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
197
1203
2.16
13.67
4.4
3.3
u/l
50.1
33.7
0.45
185
1143
(3018095) Leukocytes [#/volume] in Urine
224
1443
2.13
13.46
4.2
3.9
e6/l
114.4
77.7
0.47
152
1062
(3030467) Casts [#/volume] in Urine by Automated count
193
1176
2.15
13.40
3.3
3.3
e6/l
0.6
0.5
0.14
138
891
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
85
363
2.66
13.37
2.8
2.4
u/l
36.4
33.1
0.39
73
310
(3012095) Magnesium [Moles/volume] in Serum or Plasma
128
661
2.32
13.37
4.1
3.3
mmol/l
0.8
0.8
0.98
119
621
(42870588) Differential panel, method unspecified - Blood
204
1271
2.13
13.35
7.2
5.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
58
201
3.17
13.34
1.9
1.9
g/l
1.7
1.5
0.65
53
175
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
204
1277
2.12
13.13
3.3
2.5
u/l
61.2
56.5
0.58
189
1181
(3013650) Neutrophils [#/volume] in Blood by Automated count
296
2147
2.17
12.73
13.4
9.5
e9/l
4.3
4.2
0.16
244
1899
(36304419) Bacteria [Presence] in Urine
183
1113
2.11
12.57
3.4
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
686
2.25
12.45
1.2
1.2
u/ml
1.8
1.4
0.26
26
187
(3002256) Pathology report gross observation
100
484
2.38
11.99
1.2
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
101
492
2.37
11.93
3.5
4.0
u/l
239.5
244.6
0.17
101
466
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
154
3.30
11.83
2.2
2.3
u/ml
0.2
0.3
1.63
21
84
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
420
3628
4.84
11.73
28.5
16.5
mg/l
32.4
26.0
3.67
396
2947
(3022096) Basophils/100 leukocytes in Blood
246
1698
2.02
11.67
7.1
5.8
%
0.6
0.7
0.34
228
1592
(3003694) ABO and Rh group [Type] in Blood
159
939
2.09
11.62
1.4
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
225
1507
2.01
11.60
3.6
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
126
681
2.19
11.58
3.2
3.1
e6/l
1.2
2.1
1.00
67
387
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
261
1845
2.03
11.52
10.2
6.0
mmol/l
1.2
1.2
3.08
246
1660
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
721
2.17
11.49
3.1
2.9
e6/l
1.0
1.1
0.18
72
420
(3001604) Monocytes [#/volume] in Blood
260
1856
1.99
10.92
7.0
5.7
e9/l
0.6
0.6
0.10
213
1604
(3019069) Monocytes/100 leukocytes in Blood
249
1754
1.97
10.84
7.4
6.2
%
8.9
9.0
0.17
232
1647
(3019198) Lymphocytes [#/volume] in Blood
263
1888
1.98
10.83
7.4
5.8
e9/l
2.2
1.9
0.38
223
1665
(3006504) Eosinophils/100 leukocytes in Blood
248
1745
1.97
10.83
7.2
5.9
%
2.6
2.9
1.22
230
1630
(3031040) Bacteria [#/volume] in Urine by Automated count
324
2508
2.12
10.75
5.5
4.8
e6/l
7.4
3202.7
—
5
51
(3006315) Basophils [#/volume] in Blood
260
1867
1.97
10.61
7.0
5.7
e9/l
0.0
0.0
0.60
213
1622
(3002030) Lymphocytes/100 leukocytes in Blood
251
1784
1.95
10.52
7.6
6.1
%
24.8
26.6
1.37
234
1659
(3018010) Neutrophils/100 leukocytes in Blood
248
1759
1.94
10.42
7.2
5.8
%
60.0
57.9
1.72
230
1653
(3021589) Normoblasts [#/volume] in Blood
234
1641
1.91
10.04
16.1
10.5
e9/l
0.0
0.0
0.44
186
1357
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
403
3463
3.05
9.88
27.8
15.6
ml/min/173m2
74.3
75.7
0.61
335
2883
(3013115) Eosinophils [#/volume] in Blood
261
1920
1.89
9.43
7.3
5.8
e9/l
0.2
0.2
0.96
217
1692
(3018418) pH of Serum or Plasma
184
1219
1.88
9.17
5.1
4.1
ph
7.4
7.4
1.25
40
234
(3042936) Bacteria identified in Isolate by Culture
107
590
2.08
9.10
2.6
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
66
299
2.42
9.03
1.7
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
323
2579
1.96
8.73
5.8
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
180
1201
1.85
8.65
4.2
3.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
195
1335
1.83
8.61
4.7
3.6
mmol/l
2.4
2.3
0.20
173
1150
(3007164) IgA [Mass/volume] in Serum or Plasma
114
656
2.00
8.57
1.8
1.4
g/l
2.7
2.8
0.04
55
389
(3035350) Ketones [Presence] in Urine by Test strip
248
1829
1.82
8.54
4.6
4.0
estimate
0.0
0.0
0.00
57
349
(3013707) Erythrocyte sedimentation rate by Westergren method
338
2751
2.00
8.50
4.8
4.2
mm/h
16.6
13.5
2.38
314
2511
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
232
1683
1.80
8.38
2.5
2.1
pmol/l
90.8
95.1
0.76
138
861
(3021601) Nitrite [Presence] in Urine by Test strip
247
1832
1.80
8.22
6.6
5.3
estimate
0.0
0.0
0.00
59
352
(3021960) Folate [Moles/volume] in Serum or Plasma
156
1015
1.83
8.00
1.8
1.6
nmol/l
18.7
20.7
1.01
138
840
(3009261) Glucose [Presence] in Urine by Test strip
248
1860
1.77
7.78
4.8
4.0
estimate
0.0
0.0
0.00
58
342
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
239
1805
1.71
7.04
2.4
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
30
103
3.05
7.00
1.5
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
93
537
1.93
6.79
6.3
5.5
mmol/l
1.0
1.0
0.12
87
493
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
286
2287
1.72
6.66
4.3
3.3
u/l
85.6
57.4
2.34
268
2089
(3007461) Platelets [#/volume] in Blood
428
3951
4.65
6.52
43.9
24.5
e9/l
241.2
239.9
0.14
416
3842
(3026361) Erythrocytes [#/volume] in Blood
428
3953
4.62
6.47
43.9
24.4
e12/l
4.3
4.5
6.10
414
3829
(3010813) Leukocytes [#/volume] in Blood
428
3953
4.62
6.47
43.9
24.5
e9/l
7.1
6.8
0.87
412
3828
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
174
2.50
6.44
2.5
2.1
g/l
7.9
7.4
0.65
27
126
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
174
2.50
6.44
2.5
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
174
2.50
6.44
2.5
2.1
g/l
4.1
3.8
0.62
26
121
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
163
2.53
6.32
2.3
2.1
g/l
9.3
10.4
0.74
33
135
(3018677) aPTT in Platelet poor plasma by Coagulation assay
110
687
1.80
6.23
2.8
2.0
s
31.6
29.8
0.99
110
663
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
438
1.95
6.15
4.6
3.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
39
4.22
6.14
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
265
2.18
6.10
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
121
785
1.75
6.00
3.9
3.4
mmol/l
2.5
2.5
0.82
103
698
(3002032) Base excess in Venous blood by calculation
72
401
1.95
5.80
5.0
3.6
mmol/l
0.8
2.0
1.69
63
318
(3004588) Protein electrophoresis panel - Serum or Plasma
60
313
2.06
5.80
2.9
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
223
2.24
5.76
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
363
3159
1.87
5.76
34.3
17.7
%
37.3
39.4
3.18
245
2038
(3044889) 12 lead EKG panel
322
2708
1.71
5.75
4.9
4.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
123
823
1.69
5.38
1.8
1.8
nmol/l
1235.9
1202.2
0.12
92
624
(3020630) Protein [Mass/volume] in Serum or Plasma
66
366
1.95
5.38
3.4
2.7
g/l
64.3
66.4
1.49
61
326
(3020682) Albumin/Creatinine [Ratio] in Urine
180
1328
1.60
5.34
4.2
4.1
mg/mmol
8.0
8.3
0.05
126
857
(3002179) Metamyelocytes/100 leukocytes in Blood
57
301
2.03
5.33
3.2
4.3
%
0.6
0.5
0.10
18
89
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
399
3609
2.19
5.32
5.1
5.0
mmol/l
6.4
6.1
3.54
359
3247
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
515
1.81
5.26
1.8
1.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
28
109
2.68
5.24
2.1
2.2
g/l
3.6
3.7
0.04
28
101
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
62
340
1.96
5.21
5.6
4.2
mmol/l
1.2
1.2
0.01
53
299
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
371
3283
1.85
5.14
5.0
4.6
mu/l
2.2
2.0
0.58
334
2929
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
30
123
2.54
5.08
2.4
2.3
g/l
0.0
0.0
0.00
25
112
(40761511) CBC panel - Blood by Automated count
408
3736
2.34
5.06
28.4
15.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
118
2.56
4.99
1.7
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
338
1.93
4.98
3.4
4.4
%
0.9
0.9
0.03
23
122
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
31
131
2.47
4.94
2.7
2.3
g/l
0.0
0.0
0.00
26
119
(3024928) Oxygen saturation in Venous blood
24
89
2.79
4.93
1.9
3.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
30
125
2.50
4.92
2.4
2.3
g/l
0.0
0.0
0.00
25
113
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
28
113
2.58
4.90
1.4
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
151
2.36
4.87
3.5
2.3
g/l
0.8
0.8
0.02
27
129
(3026782) Osmolality of Urine
123
843
1.64
4.85
3.6
2.9
mosm/kgh2o
554.5
567.2
0.28
100
720
(40760892) CBC W Ordered Manual Differential panel - Blood
114
767
1.66
4.83
5.1
4.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
126
871
1.63
4.79
3.6
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
83
513
1.76
4.79
1.8
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
299
1.96
4.74
3.3
4.6
%
0.0
0.1
0.78
19
96
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
704
1.67
4.71
2.0
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
168
1251
1.56
4.64
3.1
3.3
mg/l
364.1
140.1
0.33
120
833
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
181
1378
1.53
4.48
3.6
3.1
ng/l
1466.2
1367.3
0.13
165
1202
(40761536) Microorganisms panel - Urine sediment
57
320
1.90
4.47
5.9
4.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
169
1270
1.54
4.43
3.2
3.2
mmol/l
7.6
7.7
0.03
146
1039
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
114
2.46
4.32
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
43
222
2.04
4.28
3.6
2.5
%
1.1
1.2
0.39
43
222
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
210
1662
1.51
4.28
4.9
3.9
ng/l
26.6
38.7
2.28
166
1277
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
161
2.21
4.22
2.7
2.1
g/l
3.6
3.2
1.44
26
123
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
32
148
2.25
4.20
6.5
3.9
—
2.1
—
0
15
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
148
2.25
4.20
6.6
4.0
mg/l
257.0
105.0
0.34
26
119
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
13
7.04
4.18
3.6
3.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
13
7.04
4.18
3.6
3.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
191
1488
1.50
4.17
2.2
2.3
nmol/l
75.9
79.3
0.92
165
1293
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
142
2.27
4.16
2.5
2.2
g/l
34.6
37.2
1.44
26
117
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
149
2.24
4.13
6.9
4.0
mg/l
70.6
31.1
0.61
26
121
(3021440) Promyelocytes/100 leukocytes in Blood
55
315
1.85
4.06
3.6
4.5
%
0.0
0.1
2.85
21
111
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
46
250
1.94
3.98
1.7
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
24
4.24
3.90
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
223
1.98
3.89
2.7
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
58
344
1.79
3.83
1.6
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
108
2.39
3.83
6.4
4.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
30
3.74
3.66
1.4
1.7
%
10.7
11.2
0.12
11
30
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
106
2.34
3.52
1.8
2.0
%
85.8
85.7
0.01
24
99
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
69
2.68
3.51
3.3
2.8
e9/l
4.2
4.6
0.48
18
69
(3028026) IgM [Mass/volume] in Serum or Plasma
43
239
1.89
3.50
2.6
1.7
g/l
1.1
1.5
0.47
37
220
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
25
113
2.29
3.48
2.2
1.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
19
76
2.57
3.42
2.1
2.1
%
64.2
63.2
0.06
19
76
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
72
2.56
3.25
3.7
3.3
%
56.7
59.5
0.42
18
72
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
120
889
1.48
3.20
1.9
1.8
pmol/l
433.7
441.0
0.12
99
723
(1616796) Gas panel - Central venous blood
21
92
2.35
3.15
3.5
4.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
388
3596
1.69
3.10
4.5
4.9
mmol/l
4.3
4.5
3.07
356
3275
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
386
3575
1.67
3.06
4.5
4.8
mmol/l
1.4
1.4
0.72
347
3232
(3037522) Nuclear Ab [Titer] in Serum
68
450
1.61
3.02
1.3
1.3
titre
555.0
411.2
0.34
16
100
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
300
2643
1.43
2.99
4.0
3.7
pmol/l
15.2
15.0
0.65
268
2337
(3000850) Epithelial cells [#/volume] in Urine
119
892
1.46
2.97
2.6
2.7
e6/l
4.1
4.2
0.06
100
782
(3037121) Protein [Mass/volume] in Urine
29
150
2.00
2.92
4.8
3.3
g/l
0.5
0.2
1.37
18
61
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
356
1.66
2.91
1.6
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
394
3678
1.71
2.91
5.5
5.5
mmol/l
2.4
2.6
4.08
353
3335
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
111
830
1.45
2.79
1.8
1.7
mg/l
2.3
1.4
0.52
89
659
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1013
1.42
2.74
1.6
1.7
mmol/l
1.4
1.3
0.46
108
825
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
37
3.02
2.71
1.2
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
375
3473
1.55
2.69
7.3
6.5
mmol/mol
42.6
40.7
2.76
348
3188
(40758558) Short blood count panel - Blood
123
944
1.42
2.68
8.9
6.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
43
2.84
2.66
1.3
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
407
1.58
2.62
1.5
1.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
15
4.72
2.60
1.9
2.7
%
94.1
90.4
—
7
15
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
38
2.94
2.60
1.7
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
20
94
2.18
2.59
1.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
48
303
1.66
2.58
3.2
2.6
g/l
10.9
10.5
0.24
42
276
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3460
1.53
2.55
4.0
4.3
mmol/l
1.4
1.3
1.24
334
3112
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
218
1.76
2.54
1.5
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
47
297
1.65
2.52
4.0
3.8
ng/l
105.4
83.1
0.74
40
259
(3033799) Differential panel - Peritoneal fluid
6
12
5.05
2.41
1.5
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
9
27
3.38
2.40
1.7
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
52
2.55
2.38
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
327
1.60
2.35
1.8
2.3
nmol/l
12.2
12.9
0.21
38
282
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
41
2.73
2.29
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
172
1.80
2.27
2.1
3.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
80
2.17
2.21
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
80
2.17
2.21
1.2
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
67
2.28
2.20
1.3
1.4
iu/l
2.0
5.6
—
7
19
(3041096) Erythrocytes [Presence] in Urine by Automated
124
987
1.36
2.13
5.5
3.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
43
2.60
2.11
1.5
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
150
1232
1.33
2.09
2.1
2.1
u/l
156.2
283.1
1.18
136
1160
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
125
1.89
2.06
1.2
1.4
ug/g
220.5
281.6
—
10
77
(3041354) Potassium [Moles/volume] in Venous blood
15
70
2.18
2.00
4.5
2.7
mmol/l
4.0
4.1
0.29
15
70
(3035285) Chloride [Moles/volume] in Venous blood
15
70
2.18
2.00
4.5
2.7
mmol/l
102.5
105.3
1.40
15
70
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
1.4
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
1.4
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
71
2.15
1.94
2.7
2.3
—
—
—
0
0
(4062490)
9
33
2.76
1.94
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
92
2.00
1.93
1.3
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
168
1419
1.30
1.88
5.6
4.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.68
1.87
1.3
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
34
2.68
1.87
1.4
1.1
nmol/l
1.1
1.7
—
9
29
(3044242) Glucose [Moles/volume] in Arterial blood
8
28
2.89
1.87
3.0
3.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
59
2.24
1.86
1.1
1.1
—
—
—
0
0
(44813793)
6
18
3.36
1.75
1.2
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
68
2.09
1.72
1.4
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
11
48
2.32
1.72
1.5
1.2
e6/l
11879.0
24226.2
—
5
25
(3000475) Leukocytes [#/volume] in Synovial fluid
17
90
1.92
1.67
1.5
1.7
e6/l
6972.7
16694.8
0.70
11
71
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
69
2.06
1.66
4.7
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
214
1.59
1.65
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
46
322
1.48
1.64
5.5
4.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
14
3.60
1.62
1.8
2.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
20
3.03
1.58
2.3
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
85
1.92
1.57
4.5
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
124
1031
1.28
1.52
5.3
4.3
estimate
0.0
0.0
0.50
53
339
(40767503) Oxygen content in Capillary blood by calculation
16
86
1.89
1.52
3.6
3.0
%
14.3
16.2
—
10
47
(3023199) Leukocytes [#/volume] in Pleural fluid
11
51
2.19
1.51
1.5
1.2
e6/l
338.2
1539.2
—
5
33
(3005570) Glucose [Moles/volume] in Urine
9
37
2.46
1.48
2.2
2.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
62
468
1.38
1.48
2.4
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
66
504
1.36
1.47
1.8
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
16
3.15
1.44
5.4
4.6
%
57.7
49.9
—
5
16
(3026493) Urate [Moles/volume] in Serum or Plasma
126
1057
1.27
1.44
3.3
2.8
umol/l
8702.9
8121.4
0.03
108
892
(21494890) Protein electrophoresis panel - 24 hour Urine
10
46
2.20
1.41
1.6
2.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
40
2.28
1.41
1.1
1.4
nmol/l
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
201
1784
1.23
1.38
5.7
5.2
ug/l
4.4
3.2
0.28
174
1588
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
41
2.22
1.37
1.6
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
54
2.06
1.34
1.2
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
40
0.00
1.33
0.0
1.1
—
7.4
—
0
24
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
83
1.84
1.33
1.7
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
18
2.80
1.29
1.2
2.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
84
1.81
1.28
2.3
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
48
2.11
1.28
1.5
1.3
—
—
—
0
0
(4281824)
8
35
2.31
1.27
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
77
1.85
1.27
1.2
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
70
1.88
1.25
1.2
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
351
1.38
1.22
1.5
1.7
%
1.8
1.6
0.51
42
301
(4268621)
8
37
2.18
1.22
2.1
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
19
2.65
1.22
1.0
1.1
—
0.1
—
0
5
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
276
1.41
1.16
5.3
3.6
mmol/l
1.9
2.0
0.05
29
215
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
20
2.52
1.15
1.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
13
73
1.80
1.12
1.3
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
136
0.51
1.11
2.1
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
31
2.28
1.11
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
89
1.71
1.09
1.5
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
23
153
1.53
1.08
2.7
2.0
ug/l
462.5
788.8
0.39
23
142
(3009343) pH of Capillary blood
39
289
1.38
1.08
5.3
3.5
ph
7.4
7.4
—
6
35
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
82
1.73
1.06
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
29
204
1.45
1.06
3.4
2.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
22
2.29
1.03
1.6
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
22
2.29
1.03
2.2
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
22
2.29
1.03
5.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
22
2.29
1.03
5.2
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
34
2.08
1.03
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
26
180
1.47
1.03
1.5
1.3
u/ml
203.0
277.3
0.34
21
167
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
53
1.91
1.02
1.8
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
132
1.54
0.99
8.8
4.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
23
2.19
0.98
2.2
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
159
1418
1.19
0.97
4.9
4.5
%
19.3
21.3
1.35
87
710
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
1028
1.20
0.93
3.8
3.1
ug/l
0.7
0.8
0.30
86
703
(3017704) Immunofixation for Urine
6
28
2.16
0.92
1.2
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
28
2.16
0.92
3.8
3.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
71
1.71
0.89
1.2
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
111
1.55
0.89
1.6
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
144
1.48
0.89
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
43
1.88
0.87
4.0
3.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
64
1.74
0.87
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
112
1.54
0.86
1.6
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
88
1.61
0.85
1.2
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
31
1.95
0.84
1.5
1.3
—
—
—
0
0
(4024509)
6
31
1.95
0.84
2.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
57
1.77
0.84
2.6
4.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
496
0.77
0.84
10.3
8.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
32
1.89
0.82
4.5
3.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
234
1.35
0.80
3.2
3.0
e6/l
0.1
0.2
1.29
31
229
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
175
1.39
0.76
1.0
1.2
iu/ml
203.7
114.8
—
8
56
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
67
1.66
0.75
1.0
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
305
2906
1.16
0.74
39.9
21.8
g/l
328.5
332.1
7.81
305
2894
(3013512) EKG study
140
1263
1.16
0.73
5.1
4.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
203
1.35
0.72
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
18
126
1.45
0.71
6.3
3.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
142
0.63
0.71
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
146
0.61
0.70
1.7
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
526
0.80
0.70
4.9
4.8
%
32.3
31.5
0.19
31
346
(3044927) Protein electrophoresis panel - Urine
9
59
1.54
0.68
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
27
1.86
0.68
1.4
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
119
1.45
0.68
1.8
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
28
1.79
0.66
3.2
4.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.9
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
79
1.53
0.63
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
88
1.49
0.61
1.7
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
51
1.58
0.60
5.1
3.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
151
0.65
0.60
1.2
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
9.0
—
0
6
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
208
0.71
0.59
1.6
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
72
1.54
0.59
1.8
3.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
11
73
1.52
0.56
1.5
1.2
nmol/l
0.8
0.8
0.06
11
59
(21494434) Karyotype in Bone marrow
8
55
1.46
0.56
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
23
177
1.32
0.56
7.0
4.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
27
213
1.29
0.55
5.7
3.6
—
—
—
0
0
(4094501)
15
108
1.40
0.53
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
63
1.44
0.52
1.9
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
100
0.59
0.52
1.8
2.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
118
1.37
0.51
1.5
1.3
g/l
0.3
0.2
1.84
16
113
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.9
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
49
1.44
0.46
2.3
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
103
1.37
0.45
1.6
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
86
1.41
0.45
1.3
2.0
pmol/l
211.5
236.3
0.46
12
81
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
131
0.68
0.43
1.7
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
122
1.32
0.43
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
94
0.63
0.42
1.7
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.5
—
25.3
—
0
6
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
57
1.41
0.42
1.6
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
15
0.00
0.41
0.0
1.1
—
7.7
—
0
15
(3000492) Spirometry study
39
334
1.18
0.41
1.7
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
123
1.31
0.41
1.5
1.3
g/l
1.2
1.2
0.42
16
118
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
4.1
—
35.8
—
0
12
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
67
1.35
0.38
1.8
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
67
1.35
0.38
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
321
0.83
0.37
3.0
2.9
ml/min/173m2
59.2
60.9
0.15
16
127
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
81
1.37
0.36
9.1
6.2
iu/ml
327.6
155.5
—
5
11
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
27
230
1.19
0.31
7.4
3.9
—
—
—
0
0
(44790048)
7
52
1.35
0.31
1.6
1.6
—
—
—
0
0
(44790047)
7
52
1.35
0.31
1.6
1.6
—
—
—
0
0
(44806118)
7
52
1.35
0.31
1.6
1.6
—
—
—
0
0
(44790049)
7
52
1.35
0.31
1.6
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
53
1.33
0.31
1.6
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
45
401
1.14
0.31
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
75
1.34
0.30
2.4
2.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
84
1.32
0.30
1.1
1.1
—
14.4
—
0
7
(3045414) Leukocytes [Presence] in Urine
20
168
1.20
0.27
1.5
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
113
1.25
0.27
1.2
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
113
1.25
0.27
1.4
1.9
nmol/l
46.8
43.5
0.20
14
106
(40768795) Lymph node Pathology biopsy report
5
39
1.29
0.23
1.4
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.4
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.4
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.4
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(4010399)
32
287
1.12
0.21
1.7
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
9.5
—
0
12
(4306422)
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
80
1.26
0.20
1.0
1.2
—
2.7
—
0
10
(1002224) Polysomnography panel
15
127
1.19
0.20
1.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
50
1.20
0.20
1.7
3.1
nmol/l
20.6
7.2
—
6
50
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
50
1.20
0.20
3.0
2.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
122
1172
1.06
0.18
3.5
3.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
61
1.15
0.17
1.4
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
63
1.11
0.17
1.6
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
277
0.90
0.16
4.1
3.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
111
1.18
0.16
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
83
1.21
0.15
2.7
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
112
1.17
0.14
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
346
0.92
0.14
4.0
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
142
1.13
0.13
2.8
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
181
1.11
0.12
1.1
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
13
114
1.14
0.12
2.1
2.0
mg/l
13.3
12.7
0.10
13
105
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
201
1.10
0.11
1.2
1.4
—
52.0
—
0
13
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
186
0.91
0.09
1.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
64
1.10
0.08
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
66
1.06
0.08
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
74
0.81
0.07
1.2
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
76
1.05
0.07
1.0
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
78
1.03
0.07
1.0
1.2
u/l
99.4
16.6
—
8
65
(3017732) Neutrophils [#/volume] in Blood
26
245
1.07
0.07
3.6
3.0
e9/l
5.1
3.8
1.07
20
177
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
109
1.10
0.06
1.1
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
355
0.95
0.06
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
524
1.03
0.05
1.3
1.3
u/ml
30.7
15.2
0.34
14
188
(3019225) pH of Specimen
41
396
1.04
0.05
5.9
4.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
567
1.03
0.04
1.2
1.2
iu/ml
18.0
39.1
2.05
18
166
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
153
1.05
0.01
1.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
107
1.03
0.00
1.7
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
123
0.97
0.00
3.8
2.5
ug/min
110.8
62.7
—
5
68
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
157
1.02
0.00
3.1
1.8
—
—
—
0
0
(4034850)
12
121
0.99
0.00
16.8
12.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
82
818
1.00
0.00
4.9
4.5
kg/l
1.0
1.0
0.50
13
120
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
295
1.02
0.00
1.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
101.0
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
2.0
1.7
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
55
0.91
0.00
2.0
1.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
2.0
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
85
0.94
0.00
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
20.7
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
56
0.89
0.00
2.0
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
56
0.89
0.00
2.0
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
57
0.88
0.00
2.0
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.3
—
0
7
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.9
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_COLON – Carcinoma in situ of colon

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).